Financials in USD. Standardized financial statements.
A compact view of how ADC Therapeutics S.A. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $81.36M | $70.84M | $69.56M | $209.91M | $33.92M | $0 | $2.34M | $1.14M | $1.80M |
| Revenue Growth? | +14.9% | +1.8% | -66.9% | +518.9% | 0.0% | -100.0% | +105.3% | -36.8% | 0.0% |
| Cost of Revenue? | $7.67M | $5.95M | $2.53M | $3.30M | $1.39M | $141.82M | $0 | $118.09M | $85.53M |
| Gross Profit? | $73.68M | $64.89M | $67.03M | $206.61M | $32.52M | -$141.82M | $2.34M | -$116.95M | -$83.73M |
| Gross Margin? | +90.6% | +91.6% | +96.4% | +98.4% | +95.9% | 0.0% | +100.0% | -10258.4% | -4643.8% |
| Operating Expenses? | $182.06M | $195.54M | $233.01M | $329.95M | $294.24M | $77.45M | $121.74M | $127.08M | $93.47M |
| Operating Income? | -$108.38M | -$130.65M | -$165.99M | -$123.34M | -$261.72M | -$219.26M | -$119.40M | -$125.94M | -$91.67M |
| EBITDA? | -$106.50M | -$102.65M | -$145.83M | -$107.70M | -$230.53M | -$218.23M | -$114.10M | -$122.36M | -$91.33M |
| Income Before Tax | -$142.78M | -$157.68M | -$200.95M | -$156.90M | -$251.50M | -$245.96M | -$115.90M | -$122.87M | -$89.81M |
| Income Tax Expense | -$157,000 | $166,000 | $39.11M | $227,000 | -$21.48M | $327,000 | $582,000 | $224,000 | $48,000 |
| Net Income? | -$142.62M | -$157.85M | -$240.05M | -$157.13M | -$230.03M | -$246.29M | -$116.48M | -$123.10M | -$89.86M |
| EPS? | $-1.12 | $-1.62 | $-2.94 | $-1.99 | $-3.00 | $-3.77 | $-1.74 | $-2.29 | $-1.53 |
| Diluted EPS? | $-1.12 | $-1.62 | $-2.94 | $-1.99 | $-3.00 | $-3.77 | $-1.74 | $-2.29 | $-1.53 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality